Skip to main content
dan-paul-97267-unsplash

Insights

Genetics October 11, 2018

New take on CRISPR allows scientists to transport DNA to new locations

By Hanae Armitage

A new variation of gene-editing technology CRISPR allows scientists to reorganize DNA in a cell's nucleus in three dimensions, altering cell function.

With the help of a new rendition of CRISPR-Cas9 gene editing technology, scientists at Stanford have shown that it's possible to shuttle pieces of DNA around in the nucleus, affecting gene expression and cell behavior.

The study, led by Stanley Qi, PhD, hinges on a reengineered version of CRISPR called "CRISPR-genome organization" or CRISPR-GO, which can physically relocate targeted pieces of DNA.

As reported by our release:

In the proof-of-principle study, Qi investigated three distinct subregions of the nucleus using CRISPR-GO, testing an overarching hypothesis: Do genes and other genetic elements behave differently in different zones of the nucleus? So far, their data show that specific compartments and some free-floating bodies of proteins in the nucleus can sway the function of repositioned DNA. Depending on where the genetic materials are located, some nuclear regions repress gene expression and some accelerate telomere growth, and subsequently cell division. One protein body may even hold the power to suppress tumor formation.

The research is published in Cell.

DNA is often though of as a list of As, Cs, Ts and Gs, written as a string of letters that codes for a range of biology's fundamental elements. But magnified from its microscopic state, this script would appear a long, winding strand of three-dimensional rope.

Inside a cell, this molecular twine bundles up in a central compartment that acts as the control center, called the nucleus. But it's not just crammed in haphazardly, the physical location of DNA in the cell matters. Qi explains in our release:

The question of why spatial organization in a cell matters is an important one, and it's also not one that scientists agree on... CRISPR-GO could provide an opportunity to answer that question by enabling us to target, move and relocate very specific stretches of DNA, and see how their new placements in the nucleus change how they function.

As I explain in the release, CRISPR-GO connects, like the tracks of a toy train, two regions of the nucleus: the target DNA's original location and its future destination.

Qi says that in the future, they hope to understand why different locations in the nucleus can sway the function of DNA so drastically, with the intention to one day use that information to enhance human health.

Photo by Dan Paul

About Stanford Medicine

Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.

Hanae-Armitage

Associate director, content strategy

Hanae Armitage

Hanae Armitage is the associate director, content strategy at the Office of Communications. She helps guide storytelling on digital, editorial and multimedia platforms and covers artificial intelligence, genetics and biomedical data science. She also leads the production of the Stanford Medicine podcast Health Compass, which features the latest medical research at Stanford Medicine and the compelling stories of those who lead it. She is a proud banana slug (a University of California, Santa Cruz alum) and earned her master’s degree in science journalism from Boston University. Outside the office, she enjoys the outdoors, whether it’s a good hike or a dip in the ocean.